Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells
文献类型：期刊论文
| 作者 | Lin WM1,4; Karsten U2; Goletz S2; Cheng RC3; Cao Y[*]1 |
| 刊名 | VIRCHOWS ARCHIV
 |
| 出版日期 | 2010 |
| 卷号 | 456期号:4页码:403-409 |
| 关键词 | Breast cancer-initiating cells Co-expression CD44 CD173 (H2) CD174 (LeY) |
| ISSN号 | 0945-6317 |
| 通讯作者 | caoy@mail.kiz.ac.cn |
| 合作状况 | 其它 |
| 英文摘要 | Histo-blood group antigens CD173 (H2) and CD174 (Lewis Y) are known to be developmentally regulated carbohydrate antigens which are expressed to a varying degree on many human carcinomas. We hypothesized that they might represent markers of cancer-initiating cells (or cancer stem cells, CSC). In order to test this hypothesis, we examined the co-expression of CD173 and CD174 with stem cell markers CD44 and CD133 by flow cytometry analysis, immunocytochemistry, and immunohistochemistry on cell lines and tissue sections from breast cancer. In three breast cancer cell lines, the percentage of CD173(+)/CD44(+) cells ranged from 17% to > 60% and of CD174(+)/CD44(+) from 21% to 57%. In breast cancer tissue sections from 15 patients, up to 50% of tumor cells simultaneously expressed CD173, CD174, and CD44 antigens. Co-expression of CD173 and CD174 with CD133 was also observed, but to a lesser percentage. Co-immunoprecipitation and sandwich ELISA experiments on breast cancer cell lines suggested that CD173 and CD174 are carried on the CD44 molecule. The results show that in these tissues CD173 (H2) and CD174 (LeY) are associated with CD44 expression, suggesting that these carbohydrate antigens are markers of cancer-initiating cells or of early progenitors of breast carcinomas. |
| 收录类别 | SCI |
| 资助信息 | This research was supported by a grant from Yunnan Province Science and Technology Department (2008CCO15). |
| 公开日期 | 2010-08-24 |
| 源URL | [http://159.226.149.42:8088/handle/152453/3377]  |
| 专题 | 昆明动物研究所_分子病理学 昆明动物研究所_动物模型与人类重大疾病机理重点实验室 |
| 作者单位 | 1.Laboratory of Molecular and Experimental Pathology, Key Laboratory of Animal Models and Human Disease Mechanisms of CAS and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, 32 Jiaochang Donglu, Kunming, Yunnan 650223, China 2.Glycotope GmbH, Berlin-Buch, Germany 3.Department of General Surgery, First Affiliated Hospital of Kunming Medical College, Kunming, China 4.College of Life Sciences, Longyan University, Longyan, China |
| 推荐引用方式 GB/T 7714 | Lin WM,Karsten U,Goletz S,et al. Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells[J]. VIRCHOWS ARCHIV,2010,456(4):403-409. |
| APA | Lin WM,Karsten U,Goletz S,Cheng RC,&Cao Y[*].(2010).Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells.VIRCHOWS ARCHIV,456(4),403-409. |
| MLA | Lin WM,et al."Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells".VIRCHOWS ARCHIV 456.4(2010):403-409. |
入库方式： OAI收割
来源：昆明动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。